Healthcare provider profile · identity verified

Edward P Johnson, M.D.

Internal Medicine · LATROBE, PA · NPI 1518081934

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1167	375
Lisinopril	Lisinopril	729	240
Levothyroxine Sodium	Levothyroxine Sodium	591	179
Amlodipine Besylate	Amlodipine Besylate	552	181
Pantoprazole Sodium	Pantoprazole Sodium	478	156
Rosuvastatin Calcium	Rosuvastatin Calcium	459	152
Losartan Potassium	Losartan Potassium	351	126
Metformin Hcl	Metformin Hcl	340	117
Metoprolol Tartrate	Metoprolol Tartrate	283	95
Metoprolol Succinate	Metoprolol Succinate	264	85
Omeprazole	Omeprazole	237	87
Eliquis	Apixaban	229	50
Hydrochlorothiazide	Hydrochlorothiazide	228	85
Gabapentin	Gabapentin	203	55
Furosemide	Furosemide	201	56
Jardiance	Empagliflozin	196	65
Tamsulosin Hcl	Tamsulosin Hcl	183	59
Clopidogrel	Clopidogrel Bisulfate	163	46
Alendronate Sodium	Alendronate Sodium	156	46
Potassium Chloride	Potassium Chloride	148	39
Xarelto	Rivaroxaban	147	33
Allopurinol	Allopurinol	139	41
Famotidine	Famotidine	132	34
Metformin Hcl Er	Metformin Hcl	125	47
Sertraline Hcl	Sertraline Hcl	121	47
Escitalopram Oxalate	Escitalopram Oxalate	118	40
Glimepiride	Glimepiride	111	33
Synthroid	Levothyroxine Sodium	111	31
Albuterol Sulfate Hfa	Albuterol Sulfate	110	39
Fluticasone Propionate	Fluticasone Propionate	110	32
Irbesartan	Irbesartan	107	42
Pravastatin Sodium	Pravastatin Sodium	106	41
Duloxetine Hcl	Duloxetine Hcl	102	36
Ozempic	Semaglutide	100	19
Carvedilol	Carvedilol	95	29
Simvastatin	Simvastatin	92	43
Spironolactone	Spironolactone	91	32
Trazodone Hcl	Trazodone Hcl	91	31
Doxycycline Hyclate	Doxycycline Hyclate	86	73
Finasteride	Finasteride	84	23
Citalopram Hbr	Citalopram Hydrobromide	83	31
Atenolol	Atenolol	80	30
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	79	17
Alprazolam	Alprazolam	78	30
Celecoxib	Celecoxib	77	26
Mounjaro	Tirzepatide	77	suppressed
Tramadol Hcl	Tramadol Hcl	71	39
Ventolin Hfa	Albuterol Sulfate	69	17
Ezetimibe	Ezetimibe	67	20
Meloxicam	Meloxicam	63	37
Cephalexin	Cephalexin	62	47
Zolpidem Tartrate	Zolpidem Tartrate	59	20
Montelukast Sodium	Montelukast Sodium	58	18
Farxiga	Dapagliflozin Propanediol	57	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	54	16
Fluoxetine Hcl	Fluoxetine Hcl	54	15
Triamcinolone Acetonide	Triamcinolone Acetonide	53	33
Lorazepam	Lorazepam	51	24
Quetiapine Fumarate	Quetiapine Fumarate	49	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	46	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	46	15
Prednisone	Prednisone	46	21
Buspirone Hcl	Buspirone Hcl	45	16
Ondansetron Odt	Ondansetron	45	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	44	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	44	31
Chlorthalidone	Chlorthalidone	43	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	42	12
Olmesartan Medoxomil	Olmesartan Medoxomil	42	15
Oxybutynin Chloride	Oxybutynin Chloride	41	11
Bupropion Hcl Sr	Bupropion Hcl	39	suppressed
Valsartan	Valsartan	39	14
Candesartan Cilexetil	Candesartan Cilexetil	38	13
Rizatriptan	Rizatriptan Benzoate	37	suppressed
Ondansetron Hcl	Ondansetron Hcl	35	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	14
Meclizine Hcl	Meclizine Hcl	34	12
Nortriptyline Hcl	Nortriptyline Hcl	34	suppressed
Trulicity	Dulaglutide	34	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	33	suppressed
Ibandronate Sodium	Ibandronate Sodium	32	11
Methylprednisolone	Methylprednisolone	32	25
Warfarin Sodium	Warfarin Sodium	32	13
Mirtazapine	Mirtazapine	30	11
Primidone	Primidone	30	suppressed
Lamotrigine	Lamotrigine	29	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	15
Lansoprazole	Lansoprazole	27	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	27	12
Valacyclovir	Valacyclovir Hcl	27	15
Azithromycin	Azithromycin	26	21
Incruse Ellipta	Umeclidinium Bromide	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	12
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Topiramate	Topiramate	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Bumetanide	Bumetanide	23	suppressed
Enalapril Maleate	Enalapril Maleate	23	suppressed
Ibuprofen	Ibuprofen	22	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	21	21
Pregabalin	Pregabalin	21	suppressed
Clonazepam	Clonazepam	19	suppressed
Glipizide	Glipizide	19	suppressed
Glipizide Er	Glipizide	19	suppressed
Digoxin	Digoxin	18	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	18	12
Olanzapine	Olanzapine	18	suppressed
Baclofen	Baclofen	17	suppressed
Cholestyramine	Cholestyramine (With Sugar)	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	16
Amoxicillin	Amoxicillin	16	15
Aripiprazole	Aripiprazole	16	suppressed
Arnuity Ellipta	Fluticasone Furoate	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	15
Invokana	Canagliflozin	15	suppressed
Levofloxacin	Levofloxacin	15	12
Nitroglycerin	Nitroglycerin	15	14
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Repatha Syringe	Evolocumab	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Colchicine	Colchicine	14	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	14	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	14	suppressed
Jantoven	Warfarin Sodium	14	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Nystatin	Nystatin	14	11
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Diazepam	Diazepam	13	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Levemir Flexpen	Insulin Detemir	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	13	12
Tiotropium Bromide	Tiotropium Bromide	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Cartia Xt	Diltiazem Hcl	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Nystop	Nystatin	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Zyprexa	Olanzapine	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Cefuroxime	Cefuroxime Axetil	11	11
Fludrocortisone Acetate	Fludrocortisone Acetate	11	suppressed
Mirabegron Er	Mirabegron	11	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error